z-logo
Premium
Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S‐nitroso‐N‐acetylpenicillamine (SNAP) in vivo
Author(s) -
Ng Sylvia S W,
Pang Catherine C Y
Publication year - 1998
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702175
Subject(s) - mean circulatory filling pressure , snap , sodium nitroprusside , mean arterial pressure , chemistry , anesthesia , heart rate , blood pressure , nitric oxide , pharmacology , medicine , central venous pressure , computer graphics (images) , computer science
1 We studied the effects of diethylamine/NO complex (DEA/NO) and S‐nitroso‐N‐acetylpenicillamine (SNAP), relative to those of sodium nitroprusside (SNP) and nitroglycerin (NTG), on mean arterial pressure (MAP), mean circulatory filling pressure (MCFP), arterial resistance (R a ), venous resistance (R v ), heart rate (HR), cardiac output (CO) and stroke volume (SV) in groups of Inactin‐anaesthetized rats pre‐treated with i.v. mecamylamine (3.7 μmol kg −1 ) and noradrenaline (6.8 nmol kg −1  min −1 ). Doses of each that reduced MAP by 30%, 80% and the lowest dose that maximally reduced MAP were examined to allow a comparison of the compounds' dilator actions at equivalent effective depressor doses. 2 DEA/NO (4, 32 and 256 μg kg −1  min −1 ), SNAP (4, 32 and 256 μg kg −1  min −1 ) and SNP (8, 32 and 128 μg kg −1  min −1 ) caused similar dose‐dependent reductions in MAP and R a , and increases in CO and SV. NTG (0.2, 0.8 and 6.4 μg kg −1  min −1 ) dose‐dependently reduced R a , and increased CO and SV, but lowered MAP only at the highest dose. 3 DEA/NO, SNAP and SNP but not NTG lowered MCFP with efficacy: DEA/NO>SNAP>SNP. All four drugs reduced R v with efficacy: DEA/NO ≈amp; SNAP>SNP ≈amp; NTG. 4 Therefore, all compounds lowered R a and R v . DEA/NO, SNAP and SNP but not NTG reduced MCFP. The pharmacological profiles of DEA/NO and SNAP resemble SNP more than NTG.British Journal of Pharmacology (1998) 125 , 1247–1251; doi: 10.1038/sj.bjp.0702175

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom